ABBOTT LABORATORIES Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ABBOTT LABORATORIES for February 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.87 | 400 | 24,348 | 7,013,239 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.87 | 107 | 6,513 | 7,012,839 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.86 | 1,200 | 73,032 | 7,012,732 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.86 | 293 | 17,831 | 7,011,532 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.85 | 1,000 | 60,850 | 7,011,239 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.85 | 100 | 6,085 | 7,010,239 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.84 | 1,000 | 60,840 | 7,010,139 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.83 | 600 | 36,498 | 7,009,139 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.82 | 200 | 12,164 | 7,008,539 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.82 | 400 | 24,326 | 7,008,339 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.81 | 900 | 54,729 | 7,007,939 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.81 | 100 | 6,081 | 7,007,039 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.80 | 400 | 24,320 | 7,006,939 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.80 | 300 | 18,239 | 7,006,539 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.79 | 800 | 48,632 | 7,006,239 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.79 | 400 | 24,314 | 7,005,439 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.78 | 2,100 | 127,638 | 7,005,039 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.78 | 200 | 12,155 | 7,002,939 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.77 | 2,100 | 127,617 | 7,002,739 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.77 | 600 | 36,459 | 7,000,639 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.76 | 2,500 | 151,900 | 7,000,039 | 7 M to 7 M (+0.04 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.76 | 175 | 10,632 | 6,997,539 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.75 | 2,200 | 133,650 | 6,997,364 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.75 | 1,100 | 66,820 | 6,995,164 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 200 | 12,149 | 6,994,064 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 2,000 | 121,480 | 6,993,864 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 400 | 24,294 | 6,991,864 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.73 | 2,200 | 133,606 | 6,991,464 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.73 | 1,079 | 65,522 | 6,989,264 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.72 | 4,900 | 297,528 | 6,988,185 | 7 M to 7 M (+0.07 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.72 | 1,317 | 79,962 | 6,983,285 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 100 | 6,071 | 6,981,968 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 8,100 | 491,751 | 6,981,868 | 7 M to 7 M (+0.12 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 700 | 42,494 | 6,973,768 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.70 | 4,800 | 291,360 | 6,973,068 | 7 M to 7 M (+0.07 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.70 | 500 | 30,348 | 6,968,268 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.69 | 4,400 | 267,036 | 6,967,768 | 7 M to 7 M (+0.06 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.69 | 487 | 29,554 | 6,963,368 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.68 | 4,500 | 273,060 | 6,962,881 | 7 M to 7 M (+0.06 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.68 | 103 | 6,250 | 6,958,381 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.67 | 2,799 | 169,815 | 6,958,278 | 7 M to 7 M (+0.04 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.67 | 600 | 36,399 | 6,955,479 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.66 | 1,600 | 97,056 | 6,954,879 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.65 | 1,600 | 97,040 | 6,953,279 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.65 | 1,500 | 90,968 | 6,951,679 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.64 | 1,300 | 78,832 | 6,950,179 | 6.9 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.64 | 200 | 12,127 | 6,948,879 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.63 | 700 | 42,441 | 6,948,679 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.62 | 1,417 | 85,899 | 6,947,979 | 6.9 M to 6.9 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.61 | 600 | 36,366 | 6,946,562 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.61 | 14 | 848 | 6,945,962 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.60 | 700 | 42,420 | 6,945,948 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.60 | 100 | 6,060 | 6,945,248 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.59 | 600 | 36,354 | 6,945,148 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.58 | 100 | 6,058 | 6,944,548 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.58 | 100 | 6,058 | 6,944,448 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.57 | 400 | 24,228 | 6,944,348 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.56 | 500 | 30,280 | 6,943,948 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.53 | 100 | 6,053 | 6,943,448 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.52 | 100 | 6,052 | 6,943,348 | 6.9 M to 6.9 M (0.00 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Option Exercise | A | 59.94 | 182,935 | 10,965,124 | 182,935 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | LANE ANDREW H | Executive Vice Pres ... | Payment of Exercise | F | 60.17 | 605 | 36,403 | 22,294 | 22.9 K to 22.3 K (-2.64 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Option Exercise | A | 59.94 | 61,192 | 3,667,848 | 61,192 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | MANNING JOSEPH J | Senior Vice Preside ... | Grant | A | 0.00 | 11,127 | 0 | 33,162 | 22 K to 33.2 K (+50.50 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.86 | 900 | 53,874 | 184,884 | 185.8 K to 184.9 K (-0.48 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.86 | 100 | 5,986 | 185,784 | 185.9 K to 185.8 K (-0.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.86 | 400 | 23,942 | 185,884 | 186.3 K to 185.9 K (-0.21 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.85 | 1,000 | 59,850 | 186,284 | 187.3 K to 186.3 K (-0.53 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.84 | 1,100 | 65,824 | 187,284 | 188.4 K to 187.3 K (-0.58 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.83 | 1,832 | 109,609 | 188,384 | 190.2 K to 188.4 K (-0.96 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.82 | 200 | 11,964 | 190,216 | 190.4 K to 190.2 K (-0.11 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.82 | 1,200 | 71,778 | 190,416 | 191.6 K to 190.4 K (-0.63 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.81 | 100 | 5,981 | 191,616 | 191.7 K to 191.6 K (-0.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.81 | 100 | 5,981 | 191,716 | 191.8 K to 191.7 K (-0.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.80 | 1,500 | 89,700 | 191,816 | 193.3 K to 191.8 K (-0.78 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.80 | 200 | 11,959 | 193,316 | 193.5 K to 193.3 K (-0.10 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.79 | 600 | 35,874 | 193,516 | 194.1 K to 193.5 K (-0.31 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.79 | 304 | 18,175 | 194,116 | 194.4 K to 194.1 K (-0.16 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.78 | 900 | 53,802 | 194,420 | 195.3 K to 194.4 K (-0.46 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.78 | 1,300 | 77,708 | 195,320 | 196.6 K to 195.3 K (-0.66 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.77 | 2,500 | 149,425 | 196,620 | 199.1 K to 196.6 K (-1.26 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.77 | 740 | 44,226 | 199,120 | 199.9 K to 199.1 K (-0.37 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.76 | 3,419 | 204,319 | 199,860 | 203.3 K to 199.9 K (-1.68 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.76 | 1,700 | 101,584 | 203,279 | 205 K to 203.3 K (-0.83 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.75 | 3,100 | 185,225 | 204,979 | 208.1 K to 205 K (-1.49 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.75 | 106 | 6,333 | 208,079 | 208.2 K to 208.1 K (-0.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.74 | 600 | 35,844 | 208,185 | 208.8 K to 208.2 K (-0.29 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.74 | 116 | 6,929 | 208,785 | 208.9 K to 208.8 K (-0.06 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.73 | 1,600 | 95,568 | 208,901 | 210.5 K to 208.9 K (-0.76 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.73 | 100 | 5,973 | 210,501 | 210.6 K to 210.5 K (-0.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.73 | 628 | 37,507 | 210,601 | 211.2 K to 210.6 K (-0.30 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.72 | 1,294 | 77,278 | 211,229 | 212.5 K to 211.2 K (-0.61 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.71 | 2,900 | 173,159 | 212,523 | 215.4 K to 212.5 K (-1.35 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.71 | 200 | 11,941 | 215,423 | 215.6 K to 215.4 K (-0.09 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.70 | 1,900 | 113,430 | 215,623 | 217.5 K to 215.6 K (-0.87 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.70 | 901 | 53,785 | 217,523 | 218.4 K to 217.5 K (-0.41 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.69 | 2,300 | 137,287 | 218,424 | 220.7 K to 218.4 K (-1.04 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.69 | 2,999 | 178,995 | 220,724 | 223.7 K to 220.7 K (-1.34 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.68 | 2,774 | 165,552 | 223,723 | 226.5 K to 223.7 K (-1.22 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.68 | 600 | 35,805 | 226,497 | 227.1 K to 226.5 K (-0.26 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.67 | 6,028 | 359,691 | 227,097 | 233.1 K to 227.1 K (-2.59 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 38.40 | 104,642 | 4,018,253 | 104,642 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | A | 59.94 | 246,963 | 14,802,962 | 246,963 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.67 | 100 | 5,967 | 233,125 | 233.2 K to 233.1 K (-0.04 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.67 | 77 | 4,594 | 233,225 | 233.3 K to 233.2 K (-0.03 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.67 | 2,985 | 178,100 | 233,302 | 236.3 K to 233.3 K (-1.26 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.66 | 8,206 | 489,570 | 236,287 | 244.5 K to 236.3 K (-3.36 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.66 | 10 | 597 | 244,493 | 244.5 K to 244.5 K (0.00 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.66 | 3,200 | 190,896 | 244,503 | 247.7 K to 244.5 K (-1.29 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.65 | 4,794 | 285,962 | 247,703 | 252.5 K to 247.7 K (-1.90 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.65 | 600 | 35,787 | 252,497 | 253.1 K to 252.5 K (-0.24 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.64 | 1,700 | 101,388 | 253,097 | 254.8 K to 253.1 K (-0.67 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.64 | 500 | 29,818 | 254,797 | 255.3 K to 254.8 K (-0.20 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.63 | 1,600 | 95,408 | 255,297 | 256.9 K to 255.3 K (-0.62 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.60 | 22,500 | 1,341,000 | 256,897 | 279.4 K to 256.9 K (-8.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.60 | 100 | 5,960 | 279,397 | 279.5 K to 279.4 K (-0.04 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.59 | 500 | 29,795 | 279,497 | 280 K to 279.5 K (-0.18 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.59 | 500 | 29,793 | 279,997 | 280.5 K to 280 K (-0.18 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.58 | 500 | 29,790 | 280,497 | 281 K to 280.5 K (-0.18 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.56 | 180 | 10,721 | 280,997 | 281.2 K to 281 K (-0.06 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.55 | 574 | 34,179 | 281,177 | 281.8 K to 281.2 K (-0.20 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.54 | 226 | 13,456 | 281,751 | 282 K to 281.8 K (-0.08 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.53 | 989 | 58,875 | 281,977 | 283 K to 282 K (-0.35 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.52 | 728 | 43,331 | 282,966 | 283.7 K to 283 K (-0.26 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.52 | 200 | 11,903 | 283,694 | 283.9 K to 283.7 K (-0.07 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.51 | 1,172 | 69,746 | 283,894 | 285.1 K to 283.9 K (-0.41 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.50 | 1,200 | 71,400 | 285,066 | 286.3 K to 285.1 K (-0.42 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.50 | 441 | 26,237 | 286,266 | 286.7 K to 286.3 K (-0.15 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.49 | 1,419 | 84,416 | 286,707 | 288.1 K to 286.7 K (-0.49 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.48 | 300 | 17,844 | 288,126 | 288.4 K to 288.1 K (-0.10 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 59.47 | 1,100 | 65,417 | 288,426 | 289.5 K to 288.4 K (-0.38 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 38.40 | 104,642 | 4,018,253 | 289,526 | 184.9 K to 289.5 K (+56.60 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Grant | A | 0.00 | 44,909 | 0 | 184,884 | 140 K to 184.9 K (+32.08 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Option Exercise | A | 59.94 | 246,963 | 14,802,962 | 246,963 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Grant | A | 0.00 | 44,909 | 0 | 97,075 | 52.2 K to 97.1 K (+86.09 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | A | 59.94 | 110,146 | 6,602,151 | 110,146 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Grant | A | 0.00 | 20,030 | 0 | 108,367 | 88.3 K to 108.4 K (+22.67 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | A | 59.94 | 110,146 | 6,602,151 | 110,146 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Grant | A | 0.00 | 20,030 | 0 | 65,369 | 45.3 K to 65.4 K (+44.18 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 59.94 | 155,495 | 9,320,370 | 155,495 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 28,276 | 0 | 306,258 | 278 K to 306.3 K (+10.17 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Option Exercise | A | 59.94 | 110,146 | 6,602,151 | 110,146 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Grant | A | 0.00 | 20,030 | 0 | 30,010 | 10 K to 30 K (+200.70 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Option Exercise | A | 59.94 | 134,623 | 8,069,303 | 134,623 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Grant | A | 0.00 | 24,481 | 0 | 49,499 | 25 K to 49.5 K (+97.85 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | A | 59.94 | 201,229 | 12,061,666 | 201,229 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Grant | A | 0.00 | 36,593 | 0 | 165,447 | 128.9 K to 165.4 K (+28.40 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Option Exercise | A | 59.94 | 122,385 | 7,335,757 | 122,385 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | BIRD ROGER | Senior Vice Preside ... | Grant | A | 0.00 | 22,255 | 0 | 73,568 | 51.3 K to 73.6 K (+43.37 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Option Exercise | A | 59.94 | 246,963 | 14,802,962 | 246,963 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Grant | A | 0.00 | 44,909 | 0 | 145,788 | 100.9 K to 145.8 K (+44.52 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | A | 59.94 | 182,935 | 10,965,124 | 182,935 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Grant | A | 0.00 | 33,266 | 0 | 107,064 | 73.8 K to 107.1 K (+45.08 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Shrimpton Sean | Senior Vice Preside ... | Option Exercise | A | 59.94 | 110,146 | 6,602,151 | 110,146 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Shrimpton Sean | Senior Vice Preside ... | Payment of Exercise | F | 60.17 | 1,075 | 64,683 | 15,656 | 16.7 K to 15.7 K (-6.43 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Shrimpton Sean | Senior Vice Preside ... | Payment of Exercise | F | 60.17 | 1,423 | 85,622 | 16,731 | 18.2 K to 16.7 K (-7.84 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Option Exercise | A | 59.94 | 152,981 | 9,169,681 | 152,981 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Sell | S | 59.29 | 200 | 11,858 | 73,377 | 73.6 K to 73.4 K (-0.27 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Sell | S | 59.29 | 97 | 5,751 | 73,577 | 73.7 K to 73.6 K (-0.13 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Payment of Exercise | F | 60.17 | 683 | 41,096 | 73,674 | 74.4 K to 73.7 K (-0.92 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Grant | A | 0.00 | 27,819 | 0 | 74,357 | 46.5 K to 74.4 K (+59.78 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Option Exercise | A | 59.94 | 110,146 | 6,602,151 | 110,146 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Payment of Exercise | F | 60.17 | 710 | 42,721 | 8,093 | 8.8 K to 8.1 K (-8.07 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Option Exercise | A | 59.94 | 688,073 | 41,243,096 | 688,073 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Grant | A | 0.00 | 125,125 | 0 | 3,211,570 | 3.1 M to 3.2 M (+4.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Option Exercise | A | 59.94 | 246,963 | 14,802,962 | 246,963 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | YOOR BRIAN B | Executive Vice Pres ... | Grant | A | 0.00 | 44,909 | 0 | 106,567 | 61.7 K to 106.6 K (+72.84 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Option Exercise | A | 59.94 | 110,146 | 6,602,151 | 110,146 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Sell | S | 59.29 | 459 | 27,213 | 82,069 | 82.5 K to 82.1 K (-0.56 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Payment of Exercise | F | 60.17 | 571 | 34,357 | 82,528 | 83.1 K to 82.5 K (-0.69 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Payment of Exercise | F | 60.17 | 487 | 29,303 | 83,099 | 83.6 K to 83.1 K (-0.58 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Grant | A | 0.00 | 20,030 | 0 | 83,586 | 63.6 K to 83.6 K (+31.52 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | M | 22.39 | 27,733 | 620,995 | 0 | |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.29 | 100 | 6,229 | 128,854 | 129 K to 128.9 K (-0.08 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.29 | 600 | 37,371 | 128,954 | 129.6 K to 129 K (-0.46 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.28 | 400 | 24,912 | 129,554 | 130 K to 129.6 K (-0.31 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.28 | 1,340 | 83,449 | 129,954 | 131.3 K to 130 K (-1.02 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.27 | 5,660 | 352,448 | 131,294 | 137 K to 131.3 K (-4.13 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.27 | 2,501 | 155,725 | 136,954 | 139.5 K to 137 K (-1.79 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.26 | 4,613 | 287,205 | 139,455 | 144.1 K to 139.5 K (-3.20 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.26 | 2,931 | 182,469 | 144,068 | 147 K to 144.1 K (-1.99 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.25 | 6,400 | 398,400 | 146,999 | 153.4 K to 147 K (-4.17 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.25 | 1,798 | 111,917 | 153,399 | 155.2 K to 153.4 K (-1.16 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.24 | 500 | 31,120 | 155,197 | 155.7 K to 155.2 K (-0.32 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 62.24 | 890 | 55,389 | 155,697 | 156.6 K to 155.7 K (-0.57 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | M | 22.39 | 27,733 | 620,995 | 156,587 | 128.9 K to 156.6 K (+21.52 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.89 | 200 | 12,578 | 139,975 | 140.2 K to 140 K (-0.14 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.87 | 600 | 37,722 | 140,175 | 140.8 K to 140.2 K (-0.43 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.86 | 700 | 44,002 | 140,775 | 141.5 K to 140.8 K (-0.49 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.86 | 600 | 37,713 | 141,475 | 142.1 K to 141.5 K (-0.42 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.85 | 1,400 | 87,990 | 142,075 | 143.5 K to 142.1 K (-0.98 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.85 | 1,198 | 75,288 | 143,475 | 144.7 K to 143.5 K (-0.83 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.84 | 3,502 | 220,066 | 144,673 | 148.2 K to 144.7 K (-2.36 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.84 | 662 | 41,597 | 148,175 | 148.8 K to 148.2 K (-0.44 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.83 | 3,506 | 220,282 | 148,837 | 152.3 K to 148.8 K (-2.30 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.83 | 945 | 59,370 | 152,343 | 153.3 K to 152.3 K (-0.62 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.82 | 3,500 | 219,870 | 153,288 | 156.8 K to 153.3 K (-2.23 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.82 | 2,394 | 150,379 | 156,788 | 159.2 K to 156.8 K (-1.50 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.81 | 3,008 | 188,932 | 159,182 | 162.2 K to 159.2 K (-1.85 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.81 | 799 | 50,181 | 162,190 | 163 K to 162.2 K (-0.49 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.80 | 900 | 56,520 | 162,989 | 163.9 K to 163 K (-0.55 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.80 | 200 | 12,559 | 163,889 | 164.1 K to 163.9 K (-0.12 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.79 | 331 | 20,783 | 164,089 | 164.4 K to 164.1 K (-0.20 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.78 | 700 | 43,946 | 164,420 | 165.1 K to 164.4 K (-0.42 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.78 | 499 | 31,325 | 165,120 | 165.6 K to 165.1 K (-0.30 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.77 | 2,103 | 132,005 | 165,619 | 167.7 K to 165.6 K (-1.25 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.77 | 1,270 | 79,712 | 167,722 | 169 K to 167.7 K (-0.75 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.76 | 2,400 | 150,624 | 168,992 | 171.4 K to 169 K (-1.40 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.76 | 1,231 | 77,251 | 171,392 | 172.6 K to 171.4 K (-0.71 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.75 | 2,300 | 144,325 | 172,623 | 174.9 K to 172.6 K (-1.31 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.75 | 497 | 31,184 | 174,923 | 175.4 K to 174.9 K (-0.28 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.74 | 3,690 | 231,511 | 175,420 | 179.1 K to 175.4 K (-2.06 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.74 | 303 | 19,009 | 179,110 | 179.4 K to 179.1 K (-0.17 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.73 | 307 | 19,258 | 179,413 | 179.7 K to 179.4 K (-0.17 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.73 | 100 | 6,273 | 179,720 | 179.8 K to 179.7 K (-0.06 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.72 | 400 | 25,088 | 179,820 | 180.2 K to 179.8 K (-0.22 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.72 | 103 | 6,460 | 180,220 | 180.3 K to 180.2 K (-0.06 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.71 | 200 | 12,541 | 180,323 | 180.5 K to 180.3 K (-0.11 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.70 | 103 | 6,458 | 180,523 | 180.6 K to 180.5 K (-0.06 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.69 | 400 | 25,076 | 180,626 | 181 K to 180.6 K (-0.22 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.68 | 300 | 18,804 | 181,026 | 181.3 K to 181 K (-0.17 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.66 | 300 | 18,798 | 181,326 | 181.6 K to 181.3 K (-0.17 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.65 | 300 | 18,795 | 181,626 | 181.9 K to 181.6 K (-0.16 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.64 | 100 | 6,264 | 181,926 | 182 K to 181.9 K (-0.05 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.62 | 112 | 7,013 | 182,026 | 182.1 K to 182 K (-0.06 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.95 | 200 | 12,590 | 182,138 | 182.3 K to 182.1 K (-0.11 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.94 | 1,000 | 62,940 | 182,338 | 183.3 K to 182.3 K (-0.55 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.93 | 2,100 | 132,153 | 183,338 | 185.4 K to 183.3 K (-1.13 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.92 | 7,577 | 476,745 | 185,438 | 193 K to 185.4 K (-3.93 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.91 | 745 | 46,868 | 193,015 | 193.8 K to 193 K (-0.38 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.90 | 755 | 47,490 | 193,760 | 194.5 K to 193.8 K (-0.39 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.89 | 2,200 | 138,358 | 194,515 | 196.7 K to 194.5 K (-1.12 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.89 | 500 | 31,443 | 196,715 | 197.2 K to 196.7 K (-0.25 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.88 | 1,702 | 107,022 | 197,215 | 198.9 K to 197.2 K (-0.86 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.88 | 504 | 31,689 | 198,917 | 199.4 K to 198.9 K (-0.25 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.87 | 2,790 | 175,407 | 199,421 | 202.2 K to 199.4 K (-1.38 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.87 | 102 | 6,412 | 202,211 | 202.3 K to 202.2 K (-0.05 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.86 | 800 | 50,288 | 202,313 | 203.1 K to 202.3 K (-0.39 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.86 | 17,200 | 1,081,106 | 203,113 | 220.3 K to 203.1 K (-7.81 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.85 | 2,400 | 150,840 | 220,313 | 222.7 K to 220.3 K (-1.08 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.85 | 1,851 | 116,326 | 222,713 | 224.6 K to 222.7 K (-0.82 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.84 | 3,502 | 220,066 | 224,564 | 228.1 K to 224.6 K (-1.54 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.84 | 2,404 | 151,055 | 228,066 | 230.5 K to 228.1 K (-1.04 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.83 | 20,796 | 1,306,613 | 230,470 | 251.3 K to 230.5 K (-8.28 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.83 | 1,702 | 106,928 | 251,266 | 253 K to 251.3 K (-0.67 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.82 | 6,398 | 401,922 | 252,968 | 259.4 K to 253 K (-2.47 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.82 | 700 | 43,972 | 259,366 | 260.1 K to 259.4 K (-0.27 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.82 | 41,413 | 2,601,358 | 260,066 | 301.5 K to 260.1 K (-13.74 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.81 | 2,297 | 144,275 | 301,479 | 303.8 K to 301.5 K (-0.76 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.81 | 18,700 | 1,174,454 | 303,776 | 322.5 K to 303.8 K (-5.80 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.80 | 3,683 | 231,292 | 322,476 | 326.2 K to 322.5 K (-1.13 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.80 | 300 | 18,839 | 326,159 | 326.5 K to 326.2 K (-0.09 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.80 | 12,125 | 761,389 | 326,459 | 338.6 K to 326.5 K (-3.58 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.79 | 4,225 | 265,288 | 338,584 | 342.8 K to 338.6 K (-1.23 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.79 | 400 | 25,115 | 342,809 | 343.2 K to 342.8 K (-0.12 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.79 | 500 | 31,393 | 343,209 | 343.7 K to 343.2 K (-0.15 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 38.40 | 104,642 | 4,018,253 | 209,284 | |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 39.12 | 134,741 | 5,271,068 | 0 | |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 34.94 | 149,600 | 5,227,024 | 0 | |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.78 | 32,143 | 2,017,938 | 343,709 | 375.9 K to 343.7 K (-8.55 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.78 | 800 | 50,222 | 375,852 | 376.7 K to 375.9 K (-0.21 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.78 | 1,328 | 83,365 | 376,652 | 378 K to 376.7 K (-0.35 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.77 | 6,986 | 438,511 | 377,980 | 385 K to 378 K (-1.81 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.77 | 800 | 50,214 | 384,966 | 385.8 K to 385 K (-0.21 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.77 | 4,886 | 306,670 | 385,766 | 390.7 K to 385.8 K (-1.25 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.76 | 3,703 | 232,400 | 390,652 | 394.4 K to 390.7 K (-0.94 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.76 | 4,724 | 296,455 | 394,355 | 399.1 K to 394.4 K (-1.18 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.75 | 53,383 | 3,349,783 | 399,079 | 452.5 K to 399.1 K (-11.80 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.75 | 2,615 | 164,085 | 452,462 | 455.1 K to 452.5 K (-0.57 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.75 | 83,546 | 5,242,094 | 455,077 | 538.6 K to 455.1 K (-15.51 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.74 | 8,400 | 527,016 | 538,623 | 547 K to 538.6 K (-1.54 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.74 | 4,017 | 252,006 | 547,023 | 551 K to 547 K (-0.73 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.73 | 5,903 | 370,295 | 551,040 | 556.9 K to 551 K (-1.06 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.73 | 3,010 | 188,802 | 556,943 | 560 K to 556.9 K (-0.54 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.72 | 9 | 564 | 559,953 | 560 K to 560 K (0.00 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.71 | 100 | 6,271 | 559,962 | 560.1 K to 560 K (-0.02 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.71 | 500 | 31,353 | 560,062 | 560.6 K to 560.1 K (-0.09 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.70 | 356 | 22,321 | 560,562 | 560.9 K to 560.6 K (-0.06 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.70 | 300 | 18,809 | 560,918 | 561.2 K to 560.9 K (-0.05 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.69 | 300 | 18,806 | 561,218 | 561.5 K to 561.2 K (-0.05 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.68 | 1,000 | 62,680 | 561,518 | 562.5 K to 561.5 K (-0.18 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.68 | 100 | 6,268 | 562,518 | 562.6 K to 562.5 K (-0.02 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.67 | 300 | 18,800 | 562,618 | 562.9 K to 562.6 K (-0.05 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.66 | 3,303 | 206,966 | 562,918 | 566.2 K to 562.9 K (-0.58 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.66 | 500 | 31,328 | 566,221 | 566.7 K to 566.2 K (-0.09 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 62.65 | 4,400 | 275,660 | 566,721 | 571.1 K to 566.7 K (-0.77 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 38.40 | 104,642 | 4,018,253 | 571,121 | 466.5 K to 571.1 K (+22.43 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 39.12 | 134,741 | 5,271,068 | 466,479 | 331.7 K to 466.5 K (+40.62 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 34.94 | 149,600 | 5,227,024 | 331,738 | 182.1 K to 331.7 K (+82.14 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.09 | 600 | 37,854 | 52,166 | 52.8 K to 52.2 K (-1.14 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.09 | 400 | 25,234 | 52,766 | 53.2 K to 52.8 K (-0.75 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.08 | 2,400 | 151,392 | 53,166 | 55.6 K to 53.2 K (-4.32 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.08 | 100 | 6,308 | 55,566 | 55.7 K to 55.6 K (-0.18 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.07 | 1,300 | 81,991 | 55,666 | 57 K to 55.7 K (-2.28 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.06 | 3,000 | 189,180 | 56,966 | 60 K to 57 K (-5.00 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.06 | 202 | 12,737 | 59,966 | 60.2 K to 60 K (-0.34 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.05 | 2,100 | 132,405 | 60,168 | 62.3 K to 60.2 K (-3.37 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.05 | 100 | 6,305 | 62,268 | 62.4 K to 62.3 K (-0.16 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.04 | 2,400 | 151,296 | 62,368 | 64.8 K to 62.4 K (-3.71 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.04 | 400 | 25,214 | 64,768 | 65.2 K to 64.8 K (-0.61 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.03 | 1,400 | 88,242 | 65,168 | 66.6 K to 65.2 K (-2.10 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.03 | 301 | 18,971 | 66,568 | 66.9 K to 66.6 K (-0.45 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.02 | 2,443 | 153,958 | 66,869 | 69.3 K to 66.9 K (-3.52 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.02 | 400 | 25,206 | 69,312 | 69.7 K to 69.3 K (-0.57 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.01 | 17,686 | 1,114,395 | 69,712 | 87.4 K to 69.7 K (-20.24 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.01 | 5,570 | 350,938 | 87,398 | 93 K to 87.4 K (-5.99 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Option Exercise | M | 34.94 | 49,000 | 1,712,060 | 0 | |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Option Exercise | M | 27.03 | 19,600 | 529,859 | 0 | |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Option Exercise | M | 22.39 | 10,400 | 232,876 | 0 | |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Option Exercise | M | 26.19 | 4,467 | 116,981 | 0 | |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.00 | 21,789 | 1,372,707 | 92,968 | 114.8 K to 93 K (-18.99 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 63.00 | 5,303 | 334,062 | 114,757 | 120.1 K to 114.8 K (-4.42 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.99 | 3,600 | 226,764 | 120,060 | 123.7 K to 120.1 K (-2.91 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.99 | 100 | 6,299 | 123,660 | 123.8 K to 123.7 K (-0.08 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.99 | 1,346 | 84,778 | 123,760 | 125.1 K to 123.8 K (-1.08 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.98 | 1,000 | 62,980 | 125,106 | 126.1 K to 125.1 K (-0.79 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.98 | 400 | 25,190 | 126,106 | 126.5 K to 126.1 K (-0.32 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.97 | 2,000 | 125,940 | 126,506 | 128.5 K to 126.5 K (-1.56 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.97 | 200 | 12,593 | 128,506 | 128.7 K to 128.5 K (-0.16 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.96 | 2,700 | 169,992 | 128,706 | 131.4 K to 128.7 K (-2.05 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.96 | 200 | 12,591 | 131,406 | 131.6 K to 131.4 K (-0.15 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.95 | 1,100 | 69,245 | 131,606 | 132.7 K to 131.6 K (-0.83 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.93 | 200 | 12,586 | 132,706 | 132.9 K to 132.7 K (-0.15 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.91 | 200 | 12,582 | 132,906 | 133.1 K to 132.9 K (-0.15 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.90 | 100 | 6,290 | 133,106 | 133.2 K to 133.1 K (-0.08 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.90 | 200 | 12,580 | 133,206 | 133.4 K to 133.2 K (-0.15 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.89 | 200 | 12,578 | 133,406 | 133.6 K to 133.4 K (-0.15 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.88 | 400 | 25,152 | 133,606 | 134 K to 133.6 K (-0.30 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.86 | 100 | 6,286 | 134,006 | 134.1 K to 134 K (-0.07 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.85 | 100 | 6,285 | 134,106 | 134.2 K to 134.1 K (-0.07 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.85 | 200 | 12,569 | 134,206 | 134.4 K to 134.2 K (-0.15 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.84 | 100 | 6,284 | 134,406 | 134.5 K to 134.4 K (-0.07 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.83 | 527 | 33,111 | 134,506 | 135 K to 134.5 K (-0.39 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.83 | 100 | 6,283 | 135,033 | 135.1 K to 135 K (-0.07 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.82 | 300 | 18,846 | 135,133 | 135.4 K to 135.1 K (-0.22 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Sell | S | 62.81 | 200 | 12,562 | 135,433 | 135.6 K to 135.4 K (-0.15 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Buy | M | 34.94 | 49,000 | 1,712,060 | 135,633 | 86.6 K to 135.6 K (+56.56 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Buy | M | 27.03 | 19,600 | 529,859 | 86,633 | 67 K to 86.6 K (+29.24 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Buy | M | 22.39 | 10,400 | 232,876 | 67,033 | 56.6 K to 67 K (+18.36 %) |
Feb 01 2018 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Buy | M | 26.19 | 4,467 | 116,981 | 56,633 | 52.2 K to 56.6 K (+8.56 %) |